Application of stereotactic radiotherapy in the treatment of cardiovascular diseases through sympathectomy.
10.11817/j.issn.1672-7347.2025.240702
- Author:
Zhangli XIE
1
,
2
;
Liyi LIAO
3
;
Shuang ZHANG
3
;
Lin HU
3
;
Xuping LI
2
,
4
Author Information
1. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China. xiezhangli2001@
2. com.
3. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.
4. Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China. lixp0711@
- Publication Type:Review
- Keywords:
arrhythmia;
heart failure;
hypertension;
pulmonary hypertension;
stereotactic radiotherapy;
sympathectomy
- MeSH:
Radiosurgery/methods*;
Cardiovascular Diseases/radiotherapy*;
Humans;
Imaging, Three-Dimensional;
Ganglionectomy/methods*;
Ganglia, Sympathetic/radiation effects*;
Blood Vessels/physiopathology*;
Heart/physiopathology*
- From:
Journal of Central South University(Medical Sciences)
2025;50(5):747-756
- CountryChina
- Language:English
-
Abstract:
Sympathectomy, as an emerging treatment method for cardiovascular diseases, has received extensive attention in recent years. Stereotactic radiotherapy (SRT), a precise and noninvasive therapeutic technique, has gradually been introduced into interventions targeting the sympathetic nervous system and has shown promising prospects in the management of cardiovascular conditions. Using three-dimensional imaging, SRT can accurately localize sympathetic ganglia and deliver high-energy radiation to disrupt nerve fibers, thereby achieving effects similar to conventional sympathectomy while reducing surgery-related complications and shortening recovery time. It also offers the advantages of being noninvasive and causing fewer adverse effects, and thus holds potential as an alternative to traditional approaches in the future. The integration of SRT with sympathectomy opens new avenues for the treatment of cardiovascular diseases and presents broad clinical application prospects.
